Overview
Samrat Pharmachem Limited, established in 1992, primarily manufactures and sells chemicals.
A key development was the creation of a subsidiary, Samrat Remedies Limited, focusing on pharmaceutical bulk drugs and chemicals.
The company leverages its long-standing experience in chemical manufacturing to expand into pharmaceuticals, a strategic move for diversification.
Their operational strategy includes advancing their pharmaceutical segment, aiming to capture a larger market share in the industry.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
62 Cr
- Volatility
Low Risk
- P/E Ratio
0.0
- Industry P/E
34.1
- PEG Ratio
—
- P/B Ratio
0.9
- 52W High
389.00
- 52W Low
190.00
Financial Ratios
Sales CAGR
- 1Y
- 1.52%
- 3Y
- 8.83%
- 5Y
- 12.72%
- 10Y
- 17.50%
Profit CAGR
- 1Y
- 229.17%
- 3Y
- -25.48%
- 5Y
- 10.92%
- 10Y
- 42.09%
ROE
- TTM
- -4.86%
- 3Y
- 12.96%
- 5Y
- 17.52%
- 10Y
- 16.14%
ROCE
- TTM
- -2.57%
- 3Y
- 18.70%
- 5Y
- 25.33%
- 10Y
- 24.09%
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
